Literature DB >> 17198809

Does preoperative atrial fibrillation influence early and late outcomes of coronary artery bypass grafting?

Dumbor L Ngaage1, Hartzell V Schaff, Charles J Mullany, Thoralf M Sundt, Joseph A Dearani, Sunni Barnes, Richard C Daly, Thomas A Orszulak.   

Abstract

OBJECTIVE: The study objective was to describe the independent effect of preoperative atrial fibrillation on the outcome of coronary artery bypass grafting, including the causes of death (cardiac vs noncardiac).
METHODS: We analyzed the outcome of patients with preoperative atrial fibrillation who underwent on-pump coronary artery bypass grafting between 1993 and 2002 and compared them with matched controls in sinus rhythm; matching variables were age, gender, ejection fraction, and numbers of diseased coronary arteries and distal anastomoses. Direct patient follow-up focused on late complications and reinterventions, and we investigated causes for all deaths.
RESULTS: Operative mortality (1.6% vs 1.9%, P = .79) was similar in patients with preoperative atrial fibrillation (n = 257) compared with patients in sinus rhythm (n = 269). The patients with atrial fibrillation had longer hospital stays (9 +/- 6 days vs 8 +/- 6 days, P = .0008) and a trend to more frequent early readmissions (13% vs 9%, P = .08). During follow-up (median 6.7 years, maximum 12 years), late hospital admission was more frequent in patients with atrial fibrillation (59% vs 31%, P < .0001). Risk of late mortality (all causes) in patients with atrial fibrillation was increased by 40% compared with patients in sinus rhythm (P = 0.02), and the late cardiac death rate in the atrial fibrillation group was 2.8 times that of the sinus rhythm group (P = .0004). Major adverse cardiac events occurred in 70% of patients with preoperative atrial fibrillation compared with 52% of patients in preoperative sinus rhythm (P < .0001). Subsequent rhythm-related intervention, including pacemaker implantations, was more common in the atrial fibrillation group (relative risk = 2.1, P = .0027).
CONCLUSIONS: Uncorrected preoperative atrial fibrillation in patients undergoing coronary artery bypass grafting is associated with increased late cardiac morbidity and mortality and poor long-term survival. These data support consideration of atrial fibrillation surgery at the time of coronary artery bypass grafting.

Entities:  

Mesh:

Year:  2007        PMID: 17198809     DOI: 10.1016/j.jtcvs.2006.09.021

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  17 in total

Review 1.  Management of Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting: Review of the Literature.

Authors:  Ali J Khiabani; Taylan Adademir; Richard B Schuessler; Spencer J Melby; Marc R Moon; Ralph J Damiano
Journal:  Innovations (Phila)       Date:  2018 Nov/Dec

Review 2.  Atrial fibrillation in patients with coronary disease.

Authors:  Patrick M McCarthy; Jane Kruse
Journal:  J Interv Card Electrophysiol       Date:  2007-12       Impact factor: 1.900

3.  When is your surgeon good enough? When do you need a "referent surgeon"?

Authors:  Patrick M McCarthy
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

Review 4.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  J Interv Card Electrophysiol       Date:  2012-03       Impact factor: 1.900

5.  Predictive value of NT-proBNP, procalcitonin and CVP in patients with new-onset postoperative atrial fibrillation after cardiac surgery.

Authors:  Zhiwei Xu; Long Qian; Lijuan Zhang; Yang Gao; Su Huang
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

6.  Preoperative atrial fibrillation is an independent risk factor for mid-term mortality after concomitant aortic valve replacement and coronary artery bypass graft surgery.

Authors:  Akshat Saxena; Diem Dinh; Jim Dimitriou; Christopher Reid; Julian Smith; Gilbert Shardey; Andrew Newcomb
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01-03

7.  Performance of the Cox-maze IV procedure is associated with improved long-term survival in patients with atrial fibrillation undergoing cardiac surgery.

Authors:  Farah N Musharbash; Matthew R Schill; Laurie A Sinn; Richard B Schuessler; Hersh S Maniar; Marc R Moon; Spencer J Melby; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2017-09-27       Impact factor: 5.209

8.  Effect of novel modified bipolar radiofrequency ablation for preoperative atrial fibrillation combined with off-pump coronary artery bypass grafting surgery.

Authors:  Zhaolei Jiang; Nan Ma; Min Tang; Hao Liu; Fangbao Ding; Hang Yin; Ju Mei
Journal:  Heart Vessels       Date:  2014-05-13       Impact factor: 2.037

9.  Surgical therapy of atrial fibrillation.

Authors:  Martin Haensig; Ardawan Julian Rastan; David Michael Holzhey; Friedrich-Wilhelm Mohr; Jens Garbade
Journal:  Cardiol Res Pract       Date:  2012-03-25       Impact factor: 1.866

10.  Effect of Preoperative Atrial Fibrillation on Postoperative Outcome following Cardiac Surgery.

Authors:  Nael Al-Sarraf; Lukman Thalib; Anne Hughes; Michael Tolan; Vincent Young; Eillish McGovern
Journal:  Cardiol Res Pract       Date:  2012-07-30       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.